116 related articles for article (PubMed ID: 9135492)
21. Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas.
Bokemeyer C; Harstrick A; Schmoll HJ; Köhne-Wömpner CH; Schöffski P; Poliwoda H
Ann Oncol; 1992 Jun; 3(6):487-8. PubMed ID: 1498067
[TBL] [Abstract][Full Text] [Related]
22. Combination of 5-fluorouracil, adriamycin, ifosfamide and cisplatin in metastatic adult soft tissue sarcoma: results of a phase II study.
Jäger E; Klein O; Wächter B; Bernhard H; Dippold W; Meyer zum Büschenfelde KH; Knuth A
Oncology; 1996; 53(1):58-63. PubMed ID: 8570133
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.
Budd GT; Metch B; Weiss SA; Weick JK; Fabian C; Stephens RL; Balcerzak SP
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S213-6. PubMed ID: 8453701
[TBL] [Abstract][Full Text] [Related]
24. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.
Edmonson JH; Ryan LM; Blum RH; Brooks JS; Shiraki M; Frytak S; Parkinson DR
J Clin Oncol; 1993 Jul; 11(7):1269-75. PubMed ID: 8315424
[TBL] [Abstract][Full Text] [Related]
25. Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial.
Catenacci DVT; Tebbutt NC; Davidenko I; Murad AM; Al-Batran SE; Ilson DH; Tjulandin S; Gotovkin E; Karaszewska B; Bondarenko I; Tejani MA; Udrea AA; Tehfe M; De Vita F; Turkington C; Tang R; Ang A; Zhang Y; Hoang T; Sidhu R; Cunningham D
Lancet Oncol; 2017 Nov; 18(11):1467-1482. PubMed ID: 28958504
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte-macrophage colony-stimulating factor increases dose intensity of chemotherapy in small cell lung cancer. Relationship between clinical results, peripheral blood cell modifications, and bone marrow kinetics.
Paccagnella A; Favaretto A; Riccardi A; Danova M; Ghiotto C; Giordano M; Pappagallo G; Comis S; Panozzo M; Chieco-Bianchi L
Cancer; 1993 Aug; 72(3):697-706. PubMed ID: 8392903
[TBL] [Abstract][Full Text] [Related]
27. Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study.
Reichardt P; Tilgner J; Hohenberger P; Dörken B
J Clin Oncol; 1998 Apr; 16(4):1438-43. PubMed ID: 9552049
[TBL] [Abstract][Full Text] [Related]
28. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
Schütte J; Kellner R; Seeber S
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S194-8. PubMed ID: 8453697
[TBL] [Abstract][Full Text] [Related]
29. [Phase II study of docetaxel plus epirubicin versus docetaxel plus cisplatin as first-line chemotherapy for advanced breast cancer].
Wang YJ; Wu Q; Su FX; Zhou LZ; Ye ZB; Yang JQ; Ren H; Zhang J; Ding G; Fu Q; Wang N
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):541-4. PubMed ID: 19062725
[TBL] [Abstract][Full Text] [Related]
30. [A pilot study of high-dose zorubicin in advanced stages of soft tissue sarcoma in adults].
Jelić S; Tomasević Z; Kreacić M; Kovcin V; Radosavljević D; Vlajić M
Bull Cancer; 1996 Dec; 83(12):1002-7. PubMed ID: 9116363
[TBL] [Abstract][Full Text] [Related]
31. Increasing single epirubicin doses in advanced soft tissue sarcomas.
Lopez M; Vici P; Di Lauro L; Carpano S
J Clin Oncol; 2002 Mar; 20(5):1329-34. PubMed ID: 11870176
[TBL] [Abstract][Full Text] [Related]
32. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study.
Dogliotti L; Danese S; Berruti A; Zola P; Buniva T; Bottini A; Richiardi G; Moro G; Farris A; Baù MG; Porcile G
Cancer Chemother Pharmacol; 1998; 41(4):333-8. PubMed ID: 9488603
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
[TBL] [Abstract][Full Text] [Related]
35. A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology Group.
Içli F; Celik I; Aykan F; Uner A; Demirkazik A; Ozet A; Ozgüroğlu M; Taş F; Akbulut H; Firat D
Cancer; 1998 Dec; 83(12):2475-80. PubMed ID: 9874451
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
Van Glabbeke M; van Oosterom AT; Oosterhuis JW; Mouridsen H; Crowther D; Somers R; Verweij J; Santoro A; Buesa J; Tursz T
J Clin Oncol; 1999 Jan; 17(1):150-7. PubMed ID: 10458228
[TBL] [Abstract][Full Text] [Related]
37. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients.
van Oosterom AT; Mouridsen HT; Nielsen OS; Dombernowsky P; Krzemieniecki K; Judson I; Svancarova L; Spooner D; Hermans C; Van Glabbeke M; Verweij J;
Eur J Cancer; 2002 Dec; 38(18):2397-406. PubMed ID: 12460784
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
[TBL] [Abstract][Full Text] [Related]
39. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
[TBL] [Abstract][Full Text] [Related]
40. Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study.
Palumbo R; Neumaier C; Cosso M; Bertero G; Raffo P; Spadini N; Valente S; Villani G; Pastorino M; Toma S
Eur J Cancer; 1999 Jan; 35(1):66-72. PubMed ID: 10211090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
